1999
DOI: 10.1016/s0304-3940(99)00832-0
|View full text |Cite
|
Sign up to set email alerts
|

Fibroblast growth factor-1 improves the survival and regeneration of rat vagal preganglionic neurones following axon injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2002
2002
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(17 citation statements)
references
References 14 publications
0
17
0
Order By: Relevance
“…For example, after perinatal cervical vagotomies, implants of embryonic GI tract tissue into the neck near the stump of the transected vagus are able to increase preganglionic survival (Rinaman and Levitt, 1991). Furthermore, both levocartinine (Fernandez et al, 1992) and fibroblast growth factor (Jacques et al, 1999) treatments rescue some DMNX neurons. Whether these latter effects are limited to the cell bodies or whether the treatments can potentiate regeneration into the target tissues is unclear, although fibroblast growth factor has been shown to increase at least the survival of axons in the vagal trunk.…”
Section: Vagal Efferents In Contrast To Afferents Fail To Regeneratmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, after perinatal cervical vagotomies, implants of embryonic GI tract tissue into the neck near the stump of the transected vagus are able to increase preganglionic survival (Rinaman and Levitt, 1991). Furthermore, both levocartinine (Fernandez et al, 1992) and fibroblast growth factor (Jacques et al, 1999) treatments rescue some DMNX neurons. Whether these latter effects are limited to the cell bodies or whether the treatments can potentiate regeneration into the target tissues is unclear, although fibroblast growth factor has been shown to increase at least the survival of axons in the vagal trunk.…”
Section: Vagal Efferents In Contrast To Afferents Fail To Regeneratmentioning
confidence: 99%
“…Experiments designed to maximize the recovery of vagal efferent function after axotomy may need to use nerve suture (e.g., Nanobashvili et al, 1994 ), exogenous neurotrophin therapy (e.g., Jacques et al, 1999), or another technique to promote efferent regeneration. In contrast, experiments designed to minimize efferent recovery need to divide the nerve with a procedure that leaves a gap between the proximal and distal stumps.…”
Section: Implications For Structure-function Analyses Using Vagotomymentioning
confidence: 99%
“…It takes part in multiple biological processes, including embryonic development, cell growth, morphogenesis, angiogenesis and tissue repair. Acidic FGF has been examined as therapeutic protein in animal and clinical trials for skin wound and burn healing (44), wound healing of diabetic patients (62), angiogenesis (22,49), neurotrophic activity (30,64), strong anti-apoptotic function (14,68), gut epithelium protection (20), spinal cord injury repair (65). New lymph vessels growth as well as recovery of injured ischemic blood vessels is increased when using therapy with aFGF (29).…”
Section: Introductionmentioning
confidence: 99%
“…FGF1, a member of the FGF family, is a strong mitogen for glial cells and exerts potent trophic effects on neurons [4, 10, 12, 18]. Jacques et al demonstrated that exogenous FGF1 increased the number of axons regenerating the injured vagal nerve and the number of neurons surviving in the DMNV at nine weeks after injury [10].…”
Section: Introductionmentioning
confidence: 99%
“…Jacques et al demonstrated that exogenous FGF1 increased the number of axons regenerating the injured vagal nerve and the number of neurons surviving in the DMNV at nine weeks after injury [10]. Since FGF1 lacks the signal peptide, FGF1 is thought to be released upon cellular injury and to have a trophic effect on damaged neurons [3, 9].…”
Section: Introductionmentioning
confidence: 99%